È proprio vero che esistono gli angeli, oggi ne ho incontrato uno!

Stamattina in ospedale c’era una gran casino…I computer erano fuori uso, un cartello comunicava che, per i prelievi, si doveva prendere il numerino come al supermercato… per poi però scoprire che non serviva e che si doveva fare la coda in piedi… in ordine d’arrivo…Inutile dire che i quick/pre-operatori/diabetici erano

Continua a leggere

Inaugurato a Milano il Centro per la Ricerca Pediatrica Romeo ed Enrica Invernizzi

    E’ stato inaugurato questa mattina a Milano, nei nuovissimi spazi dell’Azienda Ospedaliera Polo Universitario Luigi Sacco, il Centro per la Ricerca Pediatrica Romeo ed Enrica Invernizzi. La nuova struttura, realizzata grazie al raccordo tra l’Università degli Studi di Milano, il Polo Ospedaliero Luigi Sacco e l’Ospedale dei Bambini V.

Continua a leggere

Abbott Receives FDA Approval for the FreeStyle Libre Pro™ System, a Revolutionary Diabetes Sensing Technology for Healthcare Professionals to Use with Their Patients

News Release Abbott Receives FDA Approval for the FreeStyle Libre Pro™ System, a Revolutionary Diabetes Sensing Technology for Healthcare Professionals to Use with Their Patients • FREESTYLE LIBRE PRO IS A CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM DESIGNED TO PROVIDE A CLEAR, VISUAL SNAPSHOT OF A PATIENT’S GLUCOSE LEVELS, TRENDS AND

Continua a leggere

FDA Clears Abbott’s Needle-Free CGM For Professional Use

FDA has approved Abbott’s Freestyle Libre Pro System for professional continuous glucose monitoring (CGM), which provides clinicians with 14 days’ worth of patient data so they can make more informed clinical decisions regarding diabetes management. The system does not require finger-stick calibrations and is significantly more affordable than competitive CGM

Continua a leggere

FDA approves first automated insulin delivery device for type 1 diabetes

The U.S. Food and Drug Administration today approved Medtronic’s MiniMed 670G hybrid closed looped system, the first FDA-approved device that is intended to automatically monitor glucose (sugar) and provide appropriate basal insulin doses in people 14 years of age and older with type 1 diabetes. The human pancreas naturally supplies

Continua a leggere
Skip to content